AML relapse after rituximab treatment for GvHD: Crucial role for B cells in GvL responses

Gillissen, M.A., De Jong, G., Levie, S.E., Yasuda, E., Bakker, A.Q., Evers, L.M., Pals, S.T., C. Huisman (Cynthia), Van Helden, P.M., H. Spits (Hergen), et al. Hazenberg, M.D.

2016-09-01

Bone Marrow Transplantation , Volume 51 - Issue 9 p. 1245- 1248

Additional Metadata
Persistent URL	doi.org/10.1038/bmt.2016.90, hdl.handle.net/1765/97060
Journal	Bone Marrow Transplantation
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Gillissen, M.A., De Jong, G., Levie, S.E., Yasuda, E., Bakker, A.Q., Evers, L.M., … Hazenberg, M.D. (2016). AML relapse after rituximab treatment for GvHD: Crucial role for B cells in GvL responses. Bone Marrow Transplantation, 51(9), 1245–1248. doi:10.1038/bmt.2016.90

Publication